Knockdown of LINC01279 Suppresses Gastric Cancer Proliferation and Migration by Inhibiting PI3K/Akt/mTOR Signaling Pathway

Table 1

The correlation between clinical characteristics of GC patients and LINC01279 expression.

Characteristics	Cases ()	LINC01279 expression		value
		Low	High
Gender
Male	37	16	21	0.8015
Female	33	16	17
Age
>60 years	32	17	15	0.6316
≤60 years	38	17	21
Tumor size
≤3 cm	43	25	18	0.0060
>3 cm	27	6	21
Histological grade
High, middle	29	16	13	0.6469
Low	41	25	26
Local invasion
T1-T2	34	20	14	0.0929
T3-T4	36	13	23
Lymph node metastasis
Negative	25	19	6	0.0004
Positive	45	14	31
TNM stage
I-II	33	20	13	0.0299
III-IV	37	12	25

indicates statistically significant.